Environmental pollution (Barking, Essex : 1987)

Frontiers in microbiology

microbial drug resistance (larchmont, ny)

journal of infection in developing countries

Antibiotics (Basel, Switzerland)

[1] Occurrence of carbapenemase-producing Enterobacteriaceae in a Portuguese river: bla, bla and bla among the detected genes.

[2] Oral Treatments With Probiotics and Live Vaccine Induce Unique Changes in Gut Neurochemicals and Microbiome in Chickens.

[3] Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

[4] Extract Rejuvenates the Activity of Phenicols on Selected Multi Drug Resistant Strains.

[5] frecuencia de enzimas asociadas a sensibilidad disminuida a betalactámicos en aislados de enterobacterias, caracas, venezuela frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, caracas, venezuela

[6] extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in são luís, brazil

[7] clinical usefulness of klebsiella pneumoniae carbapenemase-producing k. pneumoniae genotyping: the experience of a single-center epidemic

[8] susceptibilidad a betalactámicos y resistencia por betalactamasas de espectro extendido (blee) en enterobacteriaceae aisladas de reservorios ambientales de un hospital general en cajamarca, perú.*

[9] biocluster: tool for identification and clustering of enterobacteriaceae based on biochemical data

[10] occurrence of antimicrobial-resistant enterobacteriaceae in water from different sources in a subtropical region of argentina

[11] long-term warming shifts the composition of bacterial communities in the phyllosphere of galium album in a permanent grassland field-experiment

[12] prevalence of extended-spectrum beta-lactamases-producing microorganisms in nosocomial patients and molecular characterization of the shv type isolates

[13] impact of the introduction of an automated microbiologic system on the clinical outcomes of bloodstream infections caused by enterobacteriaceae strains

[14] identification and characterization of t5-like bacteriophages representing two novel subgroups from food products

[15] occurrence of class 1 and 2 integrons in enterobacteriaceae collected from zagazig university hospitals, egypt

[16] antibiotic resistance of enterobacteriaceae strains isolated from different animals gastrointestinal tracts

[17] carbapenem-resistant klebsiella pneumoniae isolates from egypt containing blandm-1 on incr plasmids and its association with rmtf

[18] Survey of US wastewater for carbapenem-resistant Enterobacteriaceae.

[19] Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

[20] Impact of individualized active surveillance of carbapenem-resistant enterobacteriaceae on the infection rate in intensive care units: a 3-year retrospective study in a teaching hospital of People’s Republic of China

[21] Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

[22] Molecular mechanisms related to colistin resistance in Enterobacteriaceae

[23] Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital

[24] Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan

[25] Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia

[26] Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

[27] Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

[28] Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

[29] The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

[30] Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review

[31] Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults

[32] Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia

[33] Contribution of horizontal gene transfer to the emergence of VIM-4 carbapenemase producer Enterobacteriaceae in Kuwait

[34] Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi

[35] Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children

[36] Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan

[37] Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

[38] Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae

[39] Impact of individualized active surveillance of carbapenem-resistant enterobacteriaceae on the infection rate in intensive care units: a 3-year retrospective study in a teaching hospital of People’s Republic of China

[40] Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

[41] Molecular mechanisms related to colistin resistance in Enterobacteriaceae

[42] Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital

[43] Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan

[44] Relation between flomoxef minimum inhibitory concentrations and clinical outcomes of patients treated with flomoxef for Enterobacteriaceae bacteremia

[45] Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

[46] Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

[47] Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case–control study

[48] The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

[49] Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review

[50] Ugly bugs in healthy guts! Carriage of multidrug-resistant and ESBL-producing commensal Enterobacteriaceae in the intestine of healthy Nepalese adults

[51] Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia

[52] Contribution of horizontal gene transfer to the emergence of VIM-4 carbapenemase producer Enterobacteriaceae in Kuwait

[53] Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi

[54] Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children

[55] Fecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in nursing homes in the Kinki region of Japan

[56] Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.

[57] Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.

[58] Prevalence and dissemination risk of antimicrobial-resistant Enterobacteriaceae from shared bikes in Beijing, China.

[59] Characteristics of ESLB-producing enterobacteriaceae and methicillinresistant Staphylococcus aureus (MRSA) isolated from Swiss and imported raw poultry meat collected at retail level

[60] Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.

[61] Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.

[62] Treatment of carbapenem-resistant enterobacteriaceae infections: Is there anything else?

[63] Decreasing prevalence of contamination with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) in retail chicken meat in the Netherlands.

[64] Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

[65] Occurrence of carbapenemase-producing Enterobacteriaceae in a Portuguese river: bla, bla and bla among the detected genes.

[66] Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

[67] Comparison of three methods for identification of Enterobacteriaceae

[68] Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)

[69] Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae

[70] study on mics of tigecycline in clinical isolates of carbapenem resistant enterobacteriaceae (cre) at a tertiary care centre in north india

[71] yersinia enterocolitica ve bazı enterobacteriaceae türlerinin yoğurtta canlı kalma düzeyleri (İngilizce)

[72] extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in são luís, brazil

[73] susceptibilidad a betalactámicos y resistencia por betalactamasas de espectro extendido (blee) en enterobacteriaceae aisladas de reservorios ambientales de un hospital general en cajamarca, perú.*

[74] bacteriophages contribute to the spread of antibiotic resistance genes among foodborne pathogens of the enterobacteriaceae family – a review

[75] mutations in the quinolone resistance-determining regions of gyra and parc in enterobacteriaceae isolates from brazil

[76] serine protease autotransporters of enterobacteriaceae (spates): biogenesis and function

[77] use of a selective medium with potassium tellurite to follow intestinal colonization of hospitalized patients by drug-resistant enterobacteriaceae

[78] effects of breakpoint changes on carbapenem susceptibility rates ofenterobacteriaceae: results from the sentry antimicrobial surveillance program, united states, 2008 to 2012

[79] biocluster: tool for identification and clustering of enterobacteriaceae based on biochemical data

[80] host-toxin interactions involving espc and pet, two serine protease autotransporters of the enterobacteriaceae

[81] occurrence of antimicrobial-resistant enterobacteriaceae in water from different sources in a subtropical region of argentina

[82] impact of the introduction of an automated microbiologic system on the clinical outcomes of bloodstream infections caused by enterobacteriaceae strains

[83] in vitro activity of cefepime/aai101 and comparators against cefepime non-susceptible enterobacteriaceae

[84] nosocomial infection and characterization of extended-spectrum β-lactamases-producing enterobacteriaceae in northeast brazil

[85] occurrence of class 1 and 2 integrons in enterobacteriaceae collected from zagazig university hospitals, egypt

[86] antibiotic resistance of enterobacteriaceae strains isolated from different animals gastrointestinal tracts

[87] Enterobacillus tribolii gen. nov., sp. nov., a novel member of the family Enterobacteriaceae , isolated from the gut of a red flour beetle, Tribolium castaneum

[88] A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.

[89] Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study

[90] Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients

[91] Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

[92] High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6′)-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China (Antimicrobial Agents and Chemotheraphy (2008) 52:12 (4268-4273))

[93] Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, species and .